Tracking and integrating findings across disciplines is a persistent challenge in health disparities research. UC San Francisco faculty will soon take this challenge on with a new center to coordinate research from 11 newly funded centers across the U.S. on the root causes of, and ways to eliminate, disparities in multiple chronic diseases.
Groundbreaking National Clinical Trial Halted Due to Therapy’s High Success Rates
The Friday Seminar series at the UCSF Helen Diller Family Comprehensive Cancer Center (HDFCCC), now in its third decade, continues to drive dialogue and innovation by featuring leading cancer researchers at UCSF and beyond.
The National Cancer Institute (NCI) has established the Glioblastoma Therapeutics Network (GTN) to support discovery and development of novel therapeutics for glioblastoma. UCSF is among the five teams selected to join the GTN, receiving an award of $4.2M to aid drug discovery and early clinical studies.
A revolutionary new diagnostic method for prostate cancer can detect prostate cancer cells that have spread to lymph nodes both inside and outside the pelvis, according to the UC San Francisco and UCLA team whose earlier work led to the test’s FDA approval.
UCSF Researchers Discover New Role for Erα as an RNA-Binding Protein
This summer, Ana Velázquez Mañana, MD, fellow in Medical Oncology, led UCSF’s first class of medical students from groups underrepresented in medicine.
In response to the recent adoption of the Texas Heartbeat Act (SB8) banning nearly all abortions, the Cancer Center’s Breast Oncology Program members are part of a growing effort to move the annual San Antonio Breast Cancer Symposium (SABCS) out of Texas.